Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer
Open Access
- 8 September 2022
- journal article
- review article
- Published by Bioscientifica in Endocrine Oncology
- Vol. 2 (1) , R112-R131
Abstract
Androgen signalling, through the transcription factor androgen receptor (AR), is vital to all stages of prostate development and most prostate cancer progression. AR signalling controls differentiation, morphogenesis and function of the prostate. It also drives proliferation and survival in prostate cancer cells as the tumour progresses; given this importance it is the main therapeutic target for disseminated disease. AR is also essential in the surrounding stroma, for the embryonic development of the prostate and controlling epithelial glandular development. Stromal AR is also important in cancer initiation, regulating paracrine factors that excite cancer cell proliferation, but lower stromal AR expression correlates with shorter time to progression/worse outcomes. The profile of AR target genes is different between benign and cancerous epithelial cells, between castrate resistant prostate cancer cells (CRPC) and treatment naïve cancer cells, between metastatic and primary cancer cells, and between epithelial cells and fibroblasts. This is also true of AR DNA-binding profiles. Potentially regulating the cellular specificity of AR binding and action are pioneer factors and coregulators, which control and influence the ability of AR to bind to chromatin and regulate gene expression. The expression of these factors differs between benign and cancerous cells, as well as throughout disease progression. The expression profile is also different between fibroblast and mesenchymal cell types. The functional importance of coregulators and pioneer factors in androgen signalling makes them attractive therapeutic targets, but given the contextual expression of these factors, it is essential to understand their roles in different cancerous and cell-lineage states.Keywords
This publication has 210 references indexed in Scilit:
- Androgen Receptor Influences on Body Defense System via Modulation of Innate and Adaptive Immune SystemsThe American Journal of Pathology, 2012
- Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro‐inflammatory cytokines/chemokinesEMBO Molecular Medicine, 2012
- Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cellsMolecular and Cellular Endocrinology, 2011
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesisThe EMBO Journal, 2011
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cellsThe Prostate, 2010
- Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV‐40 tag ratsThe Prostate, 2009
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate CancerCell, 2009
- FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific TranscriptionCell, 2008
- Role of the stromal microenvironment in carcinogenesis of the prostateInternational Journal of Cancer, 2003